Leukocytosis and JAK2 mutation are two risk factors in our study that are also associated with disease progression in MPNs; thus, it is possible that these risk factors contribute to death or CV events through non-cardiovascular etiologies [18,19]. Here, JAK2 is linked to Increased total leukocyte count.